Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01661283
Title Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration

peripheral nerve sheath neoplasm


Bevacizumab + Everolimus

Age Groups: adult
Covered Countries USA

No variant requirements are available.